Ask the experts about antibiotic resistance: join the #EAAD chat on Twitter

Experts from WHO/Europe, the European Centre for Disease Prevention and Control (ECDC), the European Commission directorates-general for Research and Innovation and for Health and Consumers will answer questions on antibiotic resistance during a live Twitter chat on Tuesday, 20 November 2012, from 14:00 to 15:00 UTC/GMT (15:00–16:00 CET).

The chat is part of activities throughout the WHO European Region to mark European Antibiotic Awareness Day (EAAD).

It will be jointly hosted by Danilo Lo Fo Wong, WHO/Europe; Dominique Monnet, ECDC; Adrianus Van Hengel, Directorate-General for Research and Innovation; and Koen Van Dyck, Directorate-General for Health and Consumers.

Topics for discussion include:

  • policies, prescriptions and guidelines on antibiotic resistance
  • the health impact of antibiotic resistance
  • surveillance data in European Union (EU) countries
  • EAAD
  • research on antibiotics
  • risk management of antibiotics
  • food safety and antibiotics
  • animal husbandry and antibiotics

How to send questions

Send your questions as tweets to @WHO_Europe, using the hashtag #EAAD.

If you are unable to join the live chat, leave questions for the experts on WHO/Europe’s Facebook page.

  • WHO/Europe on Facebook

After the live chat, a summary of the discussions will be available on Storify.

Background

Antibacterial drugs, also called antibiotics, are used to prevent and treat bacterial infections such as tuberculosis and bloodstream, wound, respiratory-tract and sexually transmitted infections. Their overuse, misuse and underuse have led to an increase in and the emergence of resistance to these drugs.

The more antibiotics are used, the higher the risk of resistance. The food industry’s increased use of antibiotics can lead to the further emergence of resistant bacteria and genes that threaten human health.

Antibiotic resistance, especially in relation to hospital-acquired infections, is gaining priority as a public health issue. A key reason is that new drugs are not coming on the market soon enough.